Discovery
Define objectives, population, benefit context, eligibility boundaries, governance, and legal roles.
Employers and health plans
A supported access option with governance built in.
Explore a member-centered model for evaluating high-cost specialty requests while preserving clinical independence, quality oversight, and case-specific decision-making.
The program model
A distinct pathway for organizations—and a human one for members.
The employer pathway provides structure around communication, case support, sourcing evaluation, governance, and reporting concepts. It does not replace the member’s treating clinician or guarantee savings.
Member support
Provide clear education, voluntary case initiation, navigation, and status communication.
Case oversight
Preserve clinician independence, human review, quality controls, and documented outcomes.
Governance
Review service performance, exceptions, complaints, privacy, security, and approved reporting.
Member journey
The person remains at the center of the program.
Organization-level eligibility does not approve an individual medicine or shipment.
Member receives plain-language program information.
Communications explain voluntariness, clinical boundaries, privacy, support, and conditional outcomes.
Member creates a credential and opens a case.
Support confirms the approved route for any sensitive evidence.
Case-specific evidence and sourcing are assessed.
The treating clinician relationship remains independent of employer administration.
Member receives a clear outcome and next step.
Nonparticipation or an ineligible case must be handled according to approved program rules.
Responsible cost containment
Model opportunity without promising a result.
Potential cost relief depends on the medicine, source, member eligibility, program design, fees, exchange rates, handling, and case outcome. PharmaViaRx-specific savings figures require validated data before publication.
What may be compared
Current net plan cost, reviewed international case cost, program fees, logistics, expected utilization, exceptions, and member impact using an approved methodology.
What must remain visible
Clinical independence, voluntary participation, quality evidence, regulatory uncertainty, privacy roles, fiduciary considerations, and non-guaranteed outcomes.
What is not claimed
No percentage, per-member dollar amount, guaranteed ROI, guaranteed utilization, or competitor benchmark is presented without PharmaViaRx-specific substantiation.
Implementation readiness
Decisions to make before member launch.
The operating model must define responsibilities and controls before any enrollment communication begins.
- Contracting entities, benefit role, and fiduciary analysis
- Eligible population and case boundaries
- Member communications and consent
- HIPAA, GDPR, state privacy, DPA, and BAA assessment
- Clinical, quality, sourcing, complaint, and escalation governance
- Validated reporting definitions and minimum-necessary data
Start with discovery
Build the governance before you build the savings story.
Use the employer contact path for general program questions. Do not include member health information.